- Breast Cancer: HR+ (HER2-):
Age Requirement: >= 18
Duration: 6 Month(s)
Specialist Required: Yes
Breast Cancer: HR+ (HER2+), NSCLC Systemic Therapy, Pancreatic Cancer, Uveal Melanoma: Age Requirement: >= 18
Duration: 6 Month(s)
Specialist Required: Yes
Documented Diagnosis: Yes
Medical Test Required: No
Specialist Type(s): Oncologist
Reauthorization Required: Yes
Duration of Reauthorization: = 12 month(s)
Breast Cancer: Triple Negative: Age Requirement: >= 18
Duration: 6 Month(s)
Specialist Required: Yes
Documented Diagnosis: Yes
Medical Test Required: Yes
Specialist Type(s): Oncologist
Reauthorization Required: Yes
Duration of Reauthorization: = 12 month(s)
Cervical Cancer: Duration: 6 Month(s)
Specialist Required: Yes
Documented Diagnosis: Yes
Medical Test Required: No
Specialist Type(s): Unspecified
Reauthorization Required: Yes
Duration of Reauthorization: <= 12 month(s)
Endometrial Cancer: Age Requirement: >= 18
Duration: 6 Month(s)
Specialist Required: Yes
Documented Diagnosis: Yes
Medical Test Required: No
Specialist Type(s): Oncologist
Reauthorization Required: Yes
Duration of Reauthorization: <= 6 month(s)
Ovarian Cancer: Age Requirement: >= 18
Duration: 6 Month(s)
Specialist Required: Yes
Documented Diagnosis: Yes
Medical Test Required: No
Specialist Type(s): Oncologist
Reauthorization Required: Yes
Duration of Reauthorization: = 12 month(s)
Drug Policy Based On: NCCN Guidelines
Diagnosis Types: 2 of All NCCN indications with evidence level of 2A or higher;Ovarian Cancer;Relapsed disease
- Prior Authorization: Breast Cancer: HR+ (HER2-):
Age Requirement: >= 18
Duration: 6 Month(s)
Breast Cancer: HR+ (HER2+), Endometrial Cancer, NSCLC Systemic Therapy, Ovarian Cancer, Pancreatic Cancer, Uveal Melanoma: Documented Diagnosis: Yes
Age Requirement: >= 18
Duration: 6 Month(s)
Reauthorization Required: Yes
Breast Cancer: Triple Negative: Documented Diagnosis: Yes
Medical Test Required: Yes
Age Requirement: >= 18
Duration: 6 Month(s)
Reauthorization Required: Yes
Cervical Cancer: Documented Diagnosis: Yes
Duration: 6 Month(s)
Reauthorization Required: Yes
- Step Therapy: Breast Cancer: HR+ (HER2+):
ST Single Generic
Cervical Cancer: ST Multiple Generics
|